Give cause ,sign and symptoms, madical management , nursing management, diagnosis of chickenpox
chickenpox varicella causes signs symptoms medical nursing management diagnosis

| Feature | Chickenpox | Smallpox |
|---|---|---|
| Rash distribution | Centripetal (trunk > face/limbs) | Centrifugal (face/limbs > trunk) |
| Palms & soles | Rarely affected | Frequently affected |
| Rash stages at one time | Multiple (pleomorphic) | One stage at a time |
| Vesicle type | Superficial, unilocular | Deep, multilocular, umbilicated |
| Scab formation | 4-7 days after rash | 10-14 days after rash |
| Fever pattern | Rises with each crop | Subsides with rash onset |
| Test | Details |
|---|---|
| PCR (Polymerase Chain Reaction) | Gold standard - detects VZV DNA from vesicular fluid, crusts, saliva, CSF; highest sensitivity and specificity |
| Tzanck Smear | From a vesicle base - shows multinucleate giant cells (characteristic but not specific to VZV) |
| Direct Fluorescent Antibody (DFA) | Rapid test, can confirm and type the virus; lower sensitivity than PCR |
| Viral culture | Possible but VZV grows slowly and poorly - rarely indicated |
| Serum IgM antibody | Less sensitive than PCR; not the method of choice |
| Serum IgG antibody | Used to assess immunity/susceptibility in unvaccinated persons (e.g., healthcare workers) |
| Patient Group | Drug & Dose | Duration |
|---|---|---|
| Healthy children (routine) | Not routinely recommended; case-by-case basis | - |
| Children at high risk (skin conditions, CF, diabetes, immunosuppression, chronic steroid use) | Acyclovir 20 mg/kg/dose (max 800 mg), 4× daily | 5 days |
| Adolescents and adults (≥13 years) - all recommended | Acyclovir 800 mg, 4-5× daily | 5 days |
| Severe/fulminant disease, visceral complications | IV Acyclovir 10 mg/kg every 8 hours (adjust for renal function) | Until clinical improvement |
| Immunosuppressed patients | IV Acyclovir | As above |
| Complication | Management |
|---|---|
| Secondary bacterial infection (S. aureus, Group A Streptococcus) | Appropriate antibiotics |
| Varicella pneumonia | IV Acyclovir; oxygen therapy; mechanical ventilation if severe |
| Encephalitis/cerebellar ataxia | IV Acyclovir; supportive neurological care |
| Reye syndrome | Avoid aspirin; ICU supportive care |
| Purpura fulminans / DIC | Intensive care management |
| System | Complication |
|---|---|
| Skin/Soft tissue | Secondary bacterial infection (most common), cellulitis, scarring |
| Respiratory | Varicella pneumonia (1 in 400 adults; rare in healthy children) |
| Neurological | Cerebellar ataxia, encephalitis, stroke (VZV vasculopathy) |
| Hepatic | Asymptomatic hepatitis; Reye syndrome (if aspirin used) |
| Hematological | Thrombocytopenia, purpura fulminans (DIC) |
| Cardiac | Asymptomatic myocarditis |
| Congenital | Congenital varicella syndrome (if infection before 20 weeks gestation): skin scars, limb atrophy, microcephaly, cataracts, chorioretinitis |